T0293

Metyrapone (NSC-25265) is an inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.

Metyrapone Tartrate is an inhibitor of the STEROID 11-beta-monooxygenase enzyme which is used as a test for feedback hypothalamic-pituitary mechanism in the diagnosis of Cushing SYNDROME.

3-Heptanol-d4 (Butylethylcarbinol-d4) is the deuterium-labeled form of 3-Heptanol, a product derived from the biotransformation of n-heptane. It serves as a synthetic building block for producing 4-(3-adamantyl-ureido)-butyric acid and cyclohexanecarboxylic acid derivatives, which function as sEH inhibitors. Additionally, 3-Heptanol acts as a solvent, creating a microenvironment around single-walled carbon nanotubes, and is employed in the synthesis of substituted pyrimidine derivatives. These derivatives, being phthalate analogs, target the C1 domain to study their binding affinity with the PKCα subtype.